Comprehensive Medical Weight Loss
Blaming a person for their weight is about as helpful as blaming them for their height. While science has shown that obesity is a disease largely driven by biology, many people living with obesity continue to be blamed for their…
Today the FDA approved semaglutide 2.4 mg weekly injection for chronic weight management. The brand name will be Wegovy™.* The molecule semaglutide has been used for the treatment of type II diabetes for the past 5 years at doses of…
Just published in the New England Journal, as part of a weight loss program, the addition of semaglutide helped people with obesity lose an average of 15% of their body weight during 68 weeks of treatment. This equated to an…
Saxenda is the newest medication approved by the FDA for chronic weight management. Unlike the other medications which are taken as pills or capsules, Saxenda is a once daily self-administered injection. Originally marketed as Victoza for the treatment of type…
Contrave is one of our new anti-obesity medications, or “AOMs” approved for chronic weight management in 2014. As the years have gone by, we have accumulated a lot of clinical experience with Contrave for weight loss. This article will review…
As we celebrate Men’s health month this June, how are we doing addressing obesity among men in America? Are men receiving evidence-based weight loss treatments? Men are just as likely to suffer not only from obesity, but from the 236…
